Bausch Health
BHC
283 hedge funds and large institutions have $1.68B invested in Bausch Health in 2022 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 72 increasing their positions, 98 reducing their positions, and 86 closing their positions.
90% more call options, than puts
Call options by funds: $196M | Put options by funds: $103M
0.81% more ownership
Funds ownership: 67.16% → 67.96% (+0.81%)
13% less funds holding
Funds holding: 327 → 283 (-44)
14% less capital invested
Capital invested by funds: $1.97B → $1.68B (-$284M)
27% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 98
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
50% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 86
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$78M |
| 2 |
N
Natixis
Paris,
France
|
+$51.9M |
| 3 |
MP
MFN Partners
Boston,
Massachusetts
|
+$41.7M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$24.3M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$22.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VH
ValueAct Holdings
San Francisco,
California
|
-$120M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$23.6M |
| 3 |
RCM
Redwood Capital Management
New York
|
-$23M |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$23M |
| 5 |
PIP
Permian Investment Partners
Dallas,
Texas
|
-$16.9M |
BHC Hedge Fund Activity: Q3 2022 in Review
283 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2022, worth a combined $1.68B — down 14% from $1.97B a quarter earlier.
Sellers outnumbered buyers: 86 funds closed out of BHC and 43 opened new positions — a net loss of 43 holders — while 98 trimmed existing stakes and 72 added.
The largest buyer was Franklin Resources, adding an estimated $78M. The largest seller was ValueAct Holdings, exiting entirely with an estimated $120M sold.
- 283 institutional investors held Bausch Health (BHC) as of Q3 2022, down from 327 in Q2 2022.
- Funds reported $1.68B of Bausch Health stock for Q3 2022, down 14% quarter-over-quarter.
- 43 funds opened new Bausch Health positions in Q3 2022 and 86 closed out, a net change of -43 holders.
- The largest Bausch Health buyer in Q3 2022 was Franklin Resources, an estimated $78M added.
- The largest Bausch Health seller in Q3 2022 was ValueAct Holdings, an estimated $120M sold.
Based on aggregated 13F filings for Q3 2022.